Quarterly report pursuant to Section 13 or 15(d)

Common Shares and Warrants (Detail Narrative)

v3.23.4
Common Shares and Warrants (Detail Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
Oct. 03, 2023
May 11, 2023
Oct. 26, 2023
Nov. 30, 2023
Nov. 30, 2022
Aug. 31, 2023
Granted options     85,000      
Exercise price   $ 0.95 $ 1.15 $ 1.15   $ 1.75
Term     5 years 4 years 7 days    
Stock issued during period, shares       $ 601,661    
Proced from issuance of common stock       571,578    
Transferred to trust account       33,250    
Stock based compensation       53,953 $ 68,776  
Unrecognized non-cash compensation costs       $ 39,117    
Non-vested stock options       11,750    
Option strike price       $ 3.27    
Weighted Average Remaining Contractual Life       3 months 25 days    
Exercise price       $ 0.95    
Securities Purchase Agreement [Member]            
Proced from issuance of common stock $ 73,000,000          
Purchase of common stock 889,272          
Purchase of Pre-funded warrants 729,058          
Common shares to be purchase 1,618,330          
Offering price $ 0.97          
Exercise price $ 0.97          
Net proceeds $ 1,250,000          
Equity Incentive Plan [Member]            
Description of incentives plan       The Company has established an Equity Incentive Plan which was most recently amended by the Company’s shareholders on May 9, 2023. Pursuant to the amendments, the Equity Incentive Plan now has an evergreen formula, whereby on January 1 each year commencing January 1, 2024, the number of shares issuable pursuant to the Equity Incentive Plan may be increased to a number equal to up to 10% of the issued share capital on December 31 of the previous year    
Aggregate common shares issuable       1,037,544    
Additional shares to be issued       527,111